ZA200905618B - Solid forms of a Raf kinase inhibitor - Google Patents
Solid forms of a Raf kinase inhibitorInfo
- Publication number
- ZA200905618B ZA200905618B ZA200905618A ZA200905618A ZA200905618B ZA 200905618 B ZA200905618 B ZA 200905618B ZA 200905618 A ZA200905618 A ZA 200905618A ZA 200905618 A ZA200905618 A ZA 200905618A ZA 200905618 B ZA200905618 B ZA 200905618B
- Authority
- ZA
- South Africa
- Prior art keywords
- kinase inhibitor
- solid forms
- raf kinase
- raf
- solid
- Prior art date
Links
- 229940123690 Raf kinase inhibitor Drugs 0.000 title 1
- 102000051624 phosphatidylethanolamine binding protein Human genes 0.000 title 1
- 108700021017 phosphatidylethanolamine binding protein Proteins 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90445507P | 2007-03-02 | 2007-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200905618B true ZA200905618B (en) | 2010-05-26 |
Family
ID=39456506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200905618A ZA200905618B (en) | 2007-03-02 | 2009-08-13 | Solid forms of a Raf kinase inhibitor |
Country Status (25)
Country | Link |
---|---|
US (1) | US8324389B2 (es) |
EP (1) | EP2132198A1 (es) |
JP (1) | JP2010520215A (es) |
KR (1) | KR20090117833A (es) |
CN (1) | CN101679372A (es) |
AR (1) | AR065565A1 (es) |
AU (1) | AU2008251764B2 (es) |
BR (1) | BRPI0808526A2 (es) |
CA (1) | CA2678335A1 (es) |
CL (1) | CL2008000616A1 (es) |
CO (1) | CO6230987A2 (es) |
EC (1) | ECSP099673A (es) |
GT (1) | GT200900237A (es) |
IL (1) | IL200441A0 (es) |
MA (1) | MA31259B1 (es) |
MX (1) | MX2009009344A (es) |
MY (1) | MY148438A (es) |
NZ (1) | NZ579084A (es) |
PE (1) | PE20081801A1 (es) |
RU (1) | RU2483064C2 (es) |
SG (1) | SG179423A1 (es) |
TN (1) | TN2009000356A1 (es) |
TW (1) | TW200846341A (es) |
WO (1) | WO2008140850A1 (es) |
ZA (1) | ZA200905618B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100017894A (ko) * | 2007-05-23 | 2010-02-16 | 노파르티스 아게 | 갑상선 암의 치료를 위한 raf 억제제 |
US9408885B2 (en) | 2011-12-01 | 2016-08-09 | Vib Vzw | Combinations of therapeutic agents for treating melanoma |
US10098859B2 (en) | 2012-09-05 | 2018-10-16 | Amri Ssci, Llc | Cocrystals of p-coumaric acid |
KR20180018800A (ko) * | 2015-06-19 | 2018-02-21 | 신-낫 프로덕츠 엔터프라이즈 엘엘씨 | 카보플라틴 계 공-결정의 약제학적 조성물 및 이의 용도 |
EP3579872A1 (en) | 2017-02-10 | 2019-12-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the mapk pathway |
CA3086765A1 (en) | 2017-12-28 | 2019-07-04 | Tract Pharmaceuticals, Inc. | Stem cell culture systems for columnar epithelial stem cells, and uses related thereto |
RU2693004C1 (ru) * | 2019-03-15 | 2019-07-01 | Лейсан Фаридовна Минигулова | Противоопухолевая композиция цисплатина с ингибитором 6-фосфоглюконатдегидрогеназы |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
MXPA04009541A (es) * | 2002-03-29 | 2005-01-25 | Chiron Corp | Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf. |
TWI387592B (zh) * | 2005-08-30 | 2013-03-01 | Novartis Ag | 經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法 |
PT2046292E (pt) * | 2006-07-21 | 2010-04-26 | Novartis Ag | Formulações de éteres benzimidazolil-piridílicos |
PE20080766A1 (es) * | 2006-08-30 | 2008-06-15 | Novartis Ag | Sales de benzimidazolil piridil eteres y formulaciones que las contienen |
-
2008
- 2008-02-28 MY MYPI20093481A patent/MY148438A/en unknown
- 2008-02-28 JP JP2009551840A patent/JP2010520215A/ja active Pending
- 2008-02-28 NZ NZ579084A patent/NZ579084A/en not_active IP Right Cessation
- 2008-02-28 MX MX2009009344A patent/MX2009009344A/es active IP Right Grant
- 2008-02-28 BR BRPI0808526-9A patent/BRPI0808526A2/pt not_active IP Right Cessation
- 2008-02-28 US US12/529,258 patent/US8324389B2/en not_active Expired - Fee Related
- 2008-02-28 RU RU2009136308/04A patent/RU2483064C2/ru not_active IP Right Cessation
- 2008-02-28 EP EP08795801A patent/EP2132198A1/en not_active Withdrawn
- 2008-02-28 WO PCT/US2008/055227 patent/WO2008140850A1/en active Application Filing
- 2008-02-28 AU AU2008251764A patent/AU2008251764B2/en not_active Ceased
- 2008-02-28 KR KR1020097020657A patent/KR20090117833A/ko not_active Application Discontinuation
- 2008-02-28 CN CN200880014274A patent/CN101679372A/zh active Pending
- 2008-02-28 CA CA002678335A patent/CA2678335A1/en not_active Abandoned
- 2008-02-28 SG SG2012014676A patent/SG179423A1/en unknown
- 2008-02-29 TW TW097107217A patent/TW200846341A/zh unknown
- 2008-02-29 AR ARP080100862A patent/AR065565A1/es not_active Application Discontinuation
- 2008-02-29 PE PE2008000420A patent/PE20081801A1/es not_active Application Discontinuation
- 2008-02-29 CL CL200800616A patent/CL2008000616A1/es unknown
-
2009
- 2009-08-13 ZA ZA200905618A patent/ZA200905618B/xx unknown
- 2009-08-17 IL IL200441A patent/IL200441A0/en unknown
- 2009-08-28 TN TNP2009000356A patent/TN2009000356A1/fr unknown
- 2009-08-31 GT GT200900237A patent/GT200900237A/es unknown
- 2009-09-24 MA MA32229A patent/MA31259B1/fr unknown
- 2009-09-29 CO CO09106547A patent/CO6230987A2/es not_active Application Discontinuation
- 2009-10-02 EC EC2009009673A patent/ECSP099673A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010520215A (ja) | 2010-06-10 |
ECSP099673A (es) | 2009-11-30 |
RU2483064C2 (ru) | 2013-05-27 |
RU2009136308A (ru) | 2011-04-10 |
SG179423A1 (en) | 2012-04-27 |
MX2009009344A (es) | 2009-09-11 |
CO6230987A2 (es) | 2010-12-20 |
TN2009000356A1 (en) | 2010-12-31 |
CN101679372A (zh) | 2010-03-24 |
CA2678335A1 (en) | 2008-11-20 |
KR20090117833A (ko) | 2009-11-12 |
AR065565A1 (es) | 2009-06-17 |
MA31259B1 (fr) | 2010-03-01 |
AU2008251764B2 (en) | 2012-09-13 |
US20100209418A1 (en) | 2010-08-19 |
US8324389B2 (en) | 2012-12-04 |
NZ579084A (en) | 2012-04-27 |
IL200441A0 (en) | 2010-04-29 |
PE20081801A1 (es) | 2009-01-08 |
GT200900237A (es) | 2010-06-24 |
AU2008251764A1 (en) | 2008-11-20 |
EP2132198A1 (en) | 2009-12-16 |
TW200846341A (en) | 2008-12-01 |
MY148438A (en) | 2013-04-30 |
BRPI0808526A2 (pt) | 2014-08-19 |
CL2008000616A1 (es) | 2008-09-12 |
WO2008140850A1 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1133641A1 (zh) | 激酶抑製劑化合物 | |
HK1137295A1 (en) | Kinase inhibitor compounds | |
ZA200901073B (en) | Kinase inhibitor | |
ZA201108048B (en) | P38map kinase inhibitor | |
EP2519517A4 (en) | TYPE II RAF KINASE INHIBITORS | |
IL216511A0 (en) | Janus kinase inhibitor compounds and methods | |
IL213464A0 (en) | Kinase inhibitor compounds | |
HK1140767A1 (en) | P70 s6 kinase inhibitors p70 s6 | |
ZA201002543B (en) | Polo-like kinase inhibitors | |
ZA201004942B (en) | Ptrrolopyrazine kinase inhibitors | |
HK1126199A1 (en) | 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors | |
EP2166857A4 (en) | KINASE INHIBITOR COMPOUNDS | |
HK1134674A1 (en) | Sulfoximines as kinase inhibitors | |
HK1151291A1 (en) | 2-benzylpyridazinone derivatives as met kinase inhibitors | |
EP2222166A4 (en) | INHIBITORS OF HETEROCYCLIC KINASES | |
ZA201103170B (en) | A triazolothiadiazole inhibitor of c-met protein kinase | |
IL200441A0 (en) | Solid forms of a raf kinase inhibitor | |
EP2036893A4 (en) | ABL Kinase Inhibitor | |
GB0603522D0 (en) | Kinase inhibition | |
EP2177529A4 (en) | NEW DE-SECRETASE INHIBITOR | |
ZA200908943B (en) | Pyrazolopyrimidinone kinase inhibitor | |
IL200048A (en) | Solid forms of microbiocide | |
IL197981A0 (en) | Kinase inhibitors | |
GB0606238D0 (en) | Kinase inhibition | |
GB0720364D0 (en) | Inhibitor |